Thema
Journal Article
12
ovarian cancer
8
Antineoplastic Agents
5
Poly(ADP-ribose) Polymerase Inhibitors
5
Research Support, Non-U.S. Gov't
5
Review
4
PARP inhibitor
3
PARP inhibitors
3
Phthalazines
3
Piperazines
3
Research Support, N.I.H., Extramural
3
WOH1JD9AR8
3
olaparib
3
poly(adenosine diphosphate ribose) polymerase (PARP) inhibitor
3
BRCA mutation
2
Clinical Trial, Phase II
2
DNA repair
2
Randomized Controlled Trial
2
bevacizumab
2
2S9ZZM9Q9V
1
886U3H6UFF
1
9QHX048FRV
1
ATM protein, human
1
Antineoplastic Agents, Phytogenic
1
Ataxia Telangiectasia Mutated Proteins
1
Australia
1
BRCA
1
BRCA1 Protein
1
BRCA1 protein, human
1
BRCA2
1
BRCA2 Protein
1
BRCA2 protein, human
1
Bevacizumab
1
CDK12 protein, human
1
Chloroquine
1
Clinical Trial, Phase I
1
Cyclin-Dependent Kinases
1
DNA-Binding Proteins
1
EC 2.4.2.30
1
EC 2.7.10.1
1
EC 2.7.11.1
1
EC 2.7.11.22
1
EC 2.7.7.-
1
EC 3.6.1.3
1
EMSY amplification
1
EMSY overexpression
1
EMSY protein, human
1
G-T mismatch-binding protein
1
HER2-low breast cancer
1
HMC2H89N35
1
mehr ...